Európai Unió - finn - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologiset lääkkeet - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Európai Unió - finn - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - immunologiset lääkkeet - kana - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).

Európai Unió - finn - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologiset lääkkeet - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Európai Unió - finn - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kana - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Európai Unió - finn - EMA (European Medicines Agency)

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue - - rokotteet - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.

Finnország - finn - Fimea (Suomen lääkevirasto)

mylan ab - sodium alendronate trihydrate - tabletti - 70 mg - alendronaatti

Európai Unió - finn - EMA (European Medicines Agency)

warner chilcott  deutschland gmbh - testosteroni - seksuaaliset toimintahäiriöt, psykologinen - sukupuolihormonit ja genitaalijärjestelmään vaikuttavat aineet, - livensa on tarkoitettu kohtelu hypoaktiivisen seksuaalisen halun häiriö (hsdd) kahden oophorectomised- ja hysterectomised (kirurgisesti aiheuttama menopaussi) naiset saavat samanaikainen estrogeenihoito.

Finnország - finn - Fimea (Suomen lääkevirasto)

dechra regulatory b.v. - thiamazole - tabletti, päällystetty - 5 mg - tiamatsoli

Finnország - finn - Fimea (Suomen lääkevirasto)

dechra regulatory b.v. - thiamazole - tabletti, päällystetty - 2.5 mg - tiamatsoli

Finnország - finn - Fimea (Suomen lääkevirasto)

le vet. beheer b.v. - thiamazole - tabletti, kalvopäällysteinen - 5 mg - tiamatsoli